Michaela Reilly

Michaela Reilly

Total lobbying returns involving this official: 18

Connections GraphMethod Pie

Official Profile

Most Recent Title
Special Adviser
Most Recent Public Body
Department of the Taoiseach
First Seen
21 January 2025
Last Seen
21 September 2026

Observed Titles

Special AdviserSpecial Advisor

Observed Public Bodies

Department of the TaoiseachDáil Éireann, the Oireachtas

Current Oireachtas Committee Memberships

No current committee memberships matched for this official.

All Lobbyists
Select methods...

Lobbying Records (Page 1 of 2)

Rehab Group

2 officials
2026-09-21
Current/Former DPOFAQ

Intent: Government action on the six priorities outlined in Rehab's Pre-Budget Submission in Budget 2027: Address the Cost of DisabilityInclusive Employment for People with Disabilities Investment in independent living supports Access to person-centred, timely, age-appropriate supports Access to specialist education and improve progression to further & higher education, training and employmentInvest in the workforce, funding & reform needed to deliver high-quality, sustainable disability services

Details: Meeting with Michaela Reilly, Special Adviser, Dept of Taoiseach to discuss Rehab's Pre-Budget Submission

Methods
Email to Deirdre Gilliane with information on Rehab's pre-budget submission and request for a meetingFollow -up email after meeting - EmailMeeting with Michaela Reilly to discuss the issues outlined above, 21 July 2026 - Meeting

Roche

4 officials
2026-09-21

Intent: The integration of evidence-based societal value metrics into national healthcare policy. A European WifOR Institute study on innovative medicines showed that investing in targeted innovative therapies yields measurable macroeconomic returns, reduces acute hospital burden, and supports workforce productivity.

Details: Reframing state expenditure on innovative pharmaceuticals as a macroeconomic investment within national health and enterprise policy.

Methods
Meeting

Roche

5 officials
2026-09-21

Intent: Securing support for three legislative provisions: (1) reforming procurement to mandate Best Price-Quality Ratio (BPQR) over lowest unit price; (2) building health resilience through open, zero-tariff supply chains without rigid localization; and (3) creating a workable PFAS transition pathway with targeted, time-limited diagnostic derogations to safeguard patient access and diagnostic supply.

Details: Revisions to the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) legislative frameworks in the context of Ireland’s H2 2026 Presidency of the Council of the European Union.

Methods
Meeting

Roche

5 officials
2026-09-21

Intent: Securing support to prioritize targeted improvements in the EU Biotech Act: (1) converting Article 27 Supplementary Protection Certificate (SPC) extension criteria from cumulative to non-cumulative; (2) streamlining multi-country clinical trial approvals by establishing a single orchestrating review body; and (3) protecting resilient global supply chains by recognizing trusted non-EU trading partners without introducing protectionist quotas.

Details: Progression and refinement of legislative proposals within the EU Biotech Act during Ireland’s H2 2026 Presidency of the Council of the European Union.

Methods
Meeting

Roche

5 officials
2026-09-21

Intent: Ensuring the National Life Science Strategy embraces and builds upon existing work delivered at a national level—specifically embedding the 2026–2029 Framework Agreement’s stepwise plan for 180-day reimbursement decision timelines, and embracing and implementing the recommendations of the National Clinical Trials Oversight Group.

Details: Integration of established national health and clinical research implementation frameworks into Ireland’s National Life Science Strategy

Methods
Meeting

Roche

9 officials
2026-09-21

Intent: Embedding metric-driven performance indicators to ensure focus on clinical trial density and speed of access to new medicines, and establishing a permanent public-private National Life Science Council to support the development and delivery of the strategy

Details: Quantitative target-setting and governance structures for Ireland’s National Life Science Strategy.

Methods
Meeting

Rockwood Consulting ULC

46 officials
2026-09-10
Current/Former DPOFAQ

Intent: Secure Government support, tax measures and policy/regulatory changes in support of the measures outlined in the Pre-Budget 2027 submission.

Details: Circulated Pre-Budget 2027 submission seeking Government support for measures, including reducing Capital Gains Tax; expanding the R&D Tax Credit; reforming the capital allowances write-off period; introducing a training voucher for staff upskilling; reducing the regulated electricity network charge, ...

Methods
Email

Guaranteed Irish

42 officials
2026-09-10

Intent: Secure Government support, tax measures and policy/regulatory changes in support of the measures outlined in the Pre-Budget 2027 submission by Guaranteed Irish.

Details: Pre-Budget 2027 policy and expenditure measuresCirculated Pre-Budget 2027 submission seeking Government support for measures, including reducing Capital Gains Tax; expanding the R&D Tax Credit; reforming the capital allowances write-off period; introducing a training voucher for staff upskilling; re, ...

Methods
Simon Harris – Minister for Finance, Department of Finance; Jack Chambers – Minister for Public Expenditure, Infrastructure, Public Service Reform and Digitalisation; Peter Burke – Minister for Enterprise, Tourism and Employment; Helen McEntee – Minister for Education and Youth; Darragh O'Brien – Minister for Climate, Energy and the Environment; Micheál Martin – Taoiseach+ those listed below - Submission